Melanoma subsequent to natalizumab exposure: A report from the RADAR (Research on Adverse Drug events And Reports) program

Ryan C. Kelm; Erika L. Hagstrom; Regine J. Mathieu; Kelsey A. Orrell; Linda Serrano; Kelly A. Mueller; Anne E. Laumann; Dennis P. West; Beatrice Nardone

doi:10.1016/j.jaad.2018.10.052

Melanoma subsequent to natalizumab exposure: A report from the RADAR (Research on Adverse Drug events And Reports) program

Ryan C. Kelm, Erika L. Hagstrom, Regine J. Mathieu, Kelsey A. Orrell, Linda Serrano, Kelly A. Mueller, Anne E. Laumann, Dennis P. West, Beatrice Nardone^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Original language	English (US)
Pages (from-to)	820-821
Number of pages	2
Journal	Journal of the American Academy of Dermatology
Volume	80
Issue number	3
DOIs	https://doi.org/10.1016/j.jaad.2018.10.052
State	Published - Mar 2019

ASJC Scopus subject areas

Dermatology

Access to Document

10.1016/j.jaad.2018.10.052

Cite this

Kelm, R. C., Hagstrom, E. L., Mathieu, R. J., Orrell, K. A., Serrano, L., Mueller, K. A., Laumann, A. E., West, D. P., & Nardone, B. (2019). Melanoma subsequent to natalizumab exposure: A report from the RADAR (Research on Adverse Drug events And Reports) program. Journal of the American Academy of Dermatology, 80(3), 820-821. https://doi.org/10.1016/j.jaad.2018.10.052

@article{b1c54bf1a28649debe83381ae14fabf6,

title = "Melanoma subsequent to natalizumab exposure: A report from the RADAR (Research on Adverse Drug events And Reports) program",

author = "Kelm, {Ryan C.} and Hagstrom, {Erika L.} and Mathieu, {Regine J.} and Orrell, {Kelsey A.} and Linda Serrano and Mueller, {Kelly A.} and Laumann, {Anne E.} and West, {Dennis P.} and Beatrice Nardone",

note = "Funding Information: Funding sources: Northwestern Medicine Enterprise Data Warehouse is supported by the National Institutes of Health's National Center for Advancing Translational Sciences (grant number UL1TR001422 ). ",

year = "2019",

month = mar,

doi = "10.1016/j.jaad.2018.10.052",

language = "English (US)",

volume = "80",

pages = "820--821",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Mosby Inc.",

number = "3",

}

TY - JOUR

T1 - Melanoma subsequent to natalizumab exposure

T2 - A report from the RADAR (Research on Adverse Drug events And Reports) program

AU - Kelm, Ryan C.

AU - Hagstrom, Erika L.

AU - Mathieu, Regine J.

AU - Orrell, Kelsey A.

AU - Serrano, Linda

AU - Mueller, Kelly A.

AU - Laumann, Anne E.

AU - West, Dennis P.

AU - Nardone, Beatrice

N1 - Funding Information: Funding sources: Northwestern Medicine Enterprise Data Warehouse is supported by the National Institutes of Health's National Center for Advancing Translational Sciences (grant number UL1TR001422 ).

PY - 2019/3

Y1 - 2019/3

UR - http://www.scopus.com/inward/record.url?scp=85057275766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057275766&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2018.10.052

DO - 10.1016/j.jaad.2018.10.052

M3 - Article

C2 - 30395915

AN - SCOPUS:85057275766

SN - 0190-9622

VL - 80

SP - 820

EP - 821

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 3

ER -

Melanoma subsequent to natalizumab exposure: A report from the RADAR (Research on Adverse Drug events And Reports) program

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this